دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Pathophysiological interactions between sarcopenia and type 2 diabetes: A two-way street influencing diagnosis and therapeutic options
doi : 10.1111/dom.15321
Non-steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes
Carolina Solis-Herrera MD 1 | Curtis Triplitt PharmD
doi : 10.1111/dom.15327
Metabolically healthy obese individuals are still at high risk for diabetes: Application of the marginal structural model
Hye Ah Lee PhD, Hyesook Park MD
doi : 10.1111/dom.15329
Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta-analysis
Alvin Kuate Defo BSc, Veselko Bakula BSc, Alessandro Pisaturo MSc, Christopher Labos MD, Simon S. Wing MD, Stella S. Daskalopoulou MD
doi : 10.1111/dom.15331
5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine
Shu Niu MS, Khalid A. Alkhuzam MS, Dawei Guan MD, Tianze Jiao PhD, Lizheng Shi PhD, Vivian Fonseca PhD, Neda Laiteerapong PhD, Mohammed K. Ali MD, Desmond A. Schatz MD, Jingchuan Guo PhD, Hui Shao PhD
doi : 10.1111/dom.15332
Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials
Hiren Patel MPharm, Kamlesh Khunti MD, Helena W. Rodbard MD, Harpreet S. Bajaj MD, Ross Bray PhD, Zbigniew Kindracki MD, Ã�ngel RodrÃguez MD
doi : 10.1111/dom.15333
Metabolic syndrome, genetic susceptibility, and risk of chronic obstructive pulmonary disease: The UK Biobank Study
Shiwen Li MS, Tingjing Zhang PhD, Honghao Yang MS, Qing Chang PhD, Yuhong Zhao PhD, Liangkai Chen PhD, Li Zhao MD, Yang Xia PhD
doi : 10.1111/dom.15334
Effects of hypoglycaemic agents on reducing surrogate metabolic parameters for the prevention of cardiovascular events and death in patients with type 2 diabetes: A systematic review and meta-analysis
Alhassane Diallo MD, Orianne Villard MD, Miguel Carlos-Bolumbu MD, Eric Renard MD, Florence Galtier MD
doi : 10.1111/dom.15335
Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial
Wolfgang Landgraf PhD, David R. Owens MD, Brian M. Frier MD, Geremia B. Bolli MD
doi : 10.1111/dom.15336
Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real-world observational study
Sharmin Shabnam PhD, Sophia Abner PhD, Clare L. Gillies PhD, Melanie J. Davies MD, Terry Dex PharmD, Kamlesh Khunti PhD, David R. Webb PhD, Francesco Zaccardi PhD, Samuel Seidu MD
doi : 10.1111/dom.15337
In people with type 2 diabetes, sarcopenia is associated with the incidence of cardiovascular disease: A prospective cohort study from the UK Biobank
Jirapitcha Boonpor MSc, Jill P. Pell MD, Frederick K. Ho PhD, Carlos Celis-Morales PhD, Stuart R. Gray PhD
doi : 10.1111/dom.15338
Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators: An exploratory analysis of the PIONEER studies
Julio Rosenstock MD, Bertrand Cariou MD, Johanna Eliasson MD, Guillaume Frappin MStat, Margit S. Kaltoft MD, Eduard Montanya MD, Filip K. Knop MD
doi : 10.1111/dom.15339
Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial
Viral N. Shah MD, Amer Al-Karadsheh MD, Cathy Barnes MD, Jose Mandry MD, Samer Nakhle MD, Karin Wernicke-Panten MD, Daniel Kramer PhD, Wolfgang Schmider PhD, Suzanne Pierre MSc, Lenore Teichert MSc, Baerbel Rotthaeuser PhD, Bhaswati Mukherjee MD, Timothy S. Bailey MD
doi : 10.1111/dom.15341
Impact of a dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta-analysis
Yucheng Yang MM, Liyun He MM, Peng Liu MM, Jialu Wang MM, Na Yang MM, Ziyi Li PhD, Fan Ping MD, Lingling Xu MD, Wei Li MD, Huabing Zhang MD, Yuxiu Li MD
doi : 10.1111/dom.15342
Beneficial effects of automated insulin delivery over one-year follow-up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics
Zoé Henry MD, Sylvie Villar Fimbel MD, Nathalie Bendelac MD, Kevin Perge MD, Charles Thivolet MD
doi : 10.1111/dom.15344
Weight change in patients with new-onset type 2 diabetes mellitus and its association with remission: Comprehensive real-world data
Jinyoung Kim MD, Bongseong Kim PhD, Mee Kyoung Kim MD, Ki-Hyun Baek MD, Ki-Ho Song MD, Kyungdo Han PhD, Hyuk-Sang Kwon MD
doi : 10.1111/dom.15345
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post-hoc analysis of the ROTATE-3 study
Tom T. G. F. Lieverse BSc, Maria J. Puchades MD, Udo D. J. Mulder MD, Michele Provenzano MD, Guido Krenning PhD, Niels Jongs PhD, Simon E. Wink MSc, Riemer H. J. A. Slart MD, Michele Andreucci MD, Luis D'Marco MD, Luca De Nicola MD, Jose L. Gorriz MD, Hiddo J. L. Heerspink PhD … See fewer authorsÂ
doi : 10.1111/dom.15346
Utility of serum β2-microglobulin for prediction of kidney outcome among patients with biopsy-proven diabetic nephropathy
Takayuki Uemura MD, Masatoshi Nishimoto MD, Masahiro Eriguchi MD, Hiroyuki Tamaki MD, Hikari Tasaki MD, Riri Furuyama MD, Fumihiro Fukata MD, Takaaki Kosugi MD, Katsuhiko Morimoto MD, Masaru Matsui MD, Ken-ichi Samejima MD, Kazuhiko Tsuruya MD … See fewer authorsÂ
doi : 10.1111/dom.15347
A model-informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong-acting dipeptidyl peptidase-4 inhibitor
Cheng Cui PhD, Fangrui Cao PhD, Iok Ian Kong MRes, Qinghe Wu MD, Fangqiong Li MD, Haiyan Li MD, Dongyang Liu PhD
doi : 10.1111/dom.15348
Global trends in the burden of chronic kidney disease attributable to type 2 diabetes: An age-period-cohort analysis
Wenli Liu MSc, Duo Zhang PhD, Ruobing Wang PhD, Junhui Chen PhD, Jiaqi Zhang MSc, Di Tao MSc, Chaonan Liu PhD
doi : 10.1111/dom.15349
Factors that determine glucose variability, defined by the coefficient of variation in continuous glucose monitoring values, in a Chinese population with type 2 diabetes
Xi Wen MMED, Huijun Yang MMED, Man Yang MMED, Wenyu Tao MMED, Jiaoli Chen, Shanshan Zhao MMED, Mingliu Yin MB, Xing Zhou, Ying Yang PhD, Yiping Li PhD
doi : 10.1111/dom.15350
Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial
Yves Reznik MD, Martin Carvalho MD, Salha Fendri MD, Gaetan Prevost MD, Lucy Chaillous MD, Jean Pierre Riveline MD, Hélène Hanaire MD, Séverine Dubois MD, Patrick Houéto MD, Hélène Pasche Msc, Beata Mianowska MD, Eric Renard MD
doi : 10.1111/dom.15351
Impact of a 4-week intensive track and field training intervention on glycaemia in adolescents with type 1 diabetes: The ChilDFiT1 study
Rebecca T. Zimmer MSc, Philipp Birnbaumer PhD, Christoph Sternad MD, Beate E. M. Zunner, Janis Schierbauer PhD, Maria Fritsch MD, Elke Fröhlich-Reiterer MD, Peter Hofmann PhD, Harald Sourij MD, Felix Aberer MD, Othmar Moser PhD
doi : 10.1111/dom.15352
Effects of CB1R inverse agonist, INV-202, in patients with features of metabolic syndrome. A randomized, placebo-controlled, double-blind phase 1b study
Glenn D. Crater MD, Karine Lalonde MSc, François Ravenelle PhD, Michael Harvey PhD, Jean-Pierre Després PhD
doi : 10.1111/dom.15353
Non-alcoholic fatty liver disease is associated with brain function disruption in type 2 diabetes patients without cognitive impairment
Xin Li MM, Wen Zhang PhD, Yan Bi PhD, Jiu Chen PhD, Linqing Fu BS, Zhou Zhang PhD, Qian Chen PhD, Xin Zhang MS, Zhengyang Zhu BS, Bing Zhang PhD
doi : 10.1111/dom.15354
Establishment and validation of a prediction model for gestational diabetes
Xia Wang MD, Caidie He MD, Nian Wu MD, Yingkuan Tian MD, Songlin An MD, Wei Chen MD, Xiang Liu MD, Haonan Zhang MD, Shimin Xiong MD, Yijun Liu PhD, Quan Li PhD, Yuanzhong Zhou PhD, Xubo Shen MD … See fewer authorsÂ
doi : 10.1111/dom.15356
Effect of artificial pancreas system use on glycaemic control among pregnant women with type 1 diabetes mellitus: A meta-analysis of randomized controlled trials
Mengyun Lei MD, Danrui Chen MM, Ping Ling MD, Chaofan Wang MD, Daizhi Yang MD, Hongrong Deng MD, Xubin Yang MD, Wen Xu MD, Jinhua Yan MD
doi : 10.1111/dom.15357
One-hour post-load glucose levels are associated with hepatic steatosis assessed by transient elastography
Francesco Andreozzi PhD, Elettra Mancuso PhD, Elisa Mazza PhD, Gaia Chiara Mannino PhD, Teresa Vanessa Fiorentino PhD, Franco Arturi MD, Elena Succurro MD, Maria Perticone MD, Angela Sciacqua MD, Tiziana Montalcini PhD, Arturo Pujia MD, Giorgio Sesti MD … See fewer authorsÂ
doi : 10.1111/dom.15358
Beinaglutide for weight management in Chinese individuals with overweight or obesity: A phase 3 randomized controlled clinical study
Kang Chen MD, Li Chen MD, Zhongyan Shan MD, Guixia Wang MD, Shen Qu MD, Guijun Qin MD, Xuefeng Yu MD, Weiquan Xin MS, Tsung-han Hsieh MD, Yiming Mu MD
doi : 10.1111/dom.15360
Sodium-glucose co-transporter-2 inhibitors are associated with kidney benefits at all degrees of albuminuria: A retrospective cohort study of adults with diabetes
Kaden K. Fujita MSc, Feng Ye MSc, David Collister MD, Scott Klarenbach MD, David J. T. Campbell MD, Derek S. Chew MD, Amity E. Quinn PhD, Paul Ronksley PhD, Darren Lau MD
doi : 10.1111/dom.15361
Effect of the dual sodium-glucose co-transporter-1 and -2 inhibitor sotagliflozin on renal outcomes in type 1 diabetes and type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
Maria Anna Bantounou MPharm, Panagiotis Sardellis BSc (Hons), Rosa Thuemmler BSc (Hons), Daniel Black Boada, Justyna Kaczmarek BSc (Hons), Ribeya Mahmood BSc (Hons), Josip Plascevic BSc (Hons), Sam Philip MD
doi : 10.1111/dom.15364
Incretin-based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta-analysis of observational studies
Samuel Igweokpala MSc, Naheemot Olaoluwa Sule MSc, Antonios Douros MD, Oriana H. Y. Yu MD, Kristian B. Filion PhD
doi : 10.1111/dom.15367
FOXO1 reduces STAT3 activation and causes impaired mitochondrial quality control in diabetic cardiomyopathy
Lu Zhou MD, Wating Su MD, Yafeng Wang MD, Yuefu Zhang MD, Zhongyuan Xia MD, Shaoqing Lei MD
doi : 10.1111/dom.15369
Improvement of early-phase insulin secretion is an independent factor for achieving glycaemic control: A pooled analysis of SEED and DAWN study
Lingge Feng MS, Chunxiang Chen MS, Quanle Guo MS, Li Chen PhD, Wenying Yang MD
doi : 10.1111/dom.15370
Nasal glucagon is safe and effective in children and adolescents with type 1 diabetes: A real-world prospective cohort study
Stefano Zucchini MD, Carlo Ripoli MD, Valentino Cherubini MD, Maria Susanna Coccioli MD, Maurizio Delvecchio MD, Rosaria De Marco MD, Roberto Franceschi MD, Francesco Gallo MD, Vanna Graziani MD, Dario Iafusco MD, Stefania Innaurato MD, Anna Lasagni MD, Fortunato Lombardo MD, Marco Marigliano MD, Sara Monti MD, Filomena Pascarella MD, Giulia Pezzino MD, Barbara Predieri MD, Ivana Rabbone MD, Riccardo Schiaffini MD, Michela Trada MD, Stefano Tumini MD, Andrea Scaramuzza MD, the Baqsimi Study Group Collaborators
doi : 10.1111/dom.15330
Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial
Abhinav Sharma MD, Pedro Marques MD, Brendon L. Neuen PhD, Robert A. Fletcher MSc, April Slee PhD, Wally Rapattoni MSc, Fernando G. Ang MD, Clare Arnott PhD, Adeera Levin MD, Subodh Verma MD, Vlado Perkovic PhD, Kenneth W. Mahaffey MD
doi : 10.1111/dom.15340
Implementing Control-IQ technology after a virtual educational camp in children and adolescents with type 1 diabetes: Does time in range plateau over 1 year?
Andrea E. Scaramuzza MD, Marco Marigliano MD, Riccardo Bonfanti MD, Valentino Cherubini MD, Riccardo Schiaffini MD, Sonia Toni MD, Ivana Rabbone MD, The vEC Study Group
doi : 10.1111/dom.15343
Artemisinin alleviates obesity-related glomerulopathy by downregulating CYP24A1 expression
Xiaorong Chen MS, Jie Xiang MS, Peng Gao PhD, Lijuan Wang BS, Li Xiang BS, Zongshi Lu MD, Tingbing Cao BS, Aidi Mou BS, Xingping Zhang PhD, Xiaoyan Jiang PhD, Zhiming Zhu MD, PhD, Hongmei Lang MD … See fewer authorsÂ
doi : 10.1111/dom.15355
Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial
Yujuan Fan MS, Mingfeng Xia PhD, Hongmei Yan PhD, Xiaoying Li PhD, Xinxia Chang PhD
doi : 10.1111/dom.15359
Obesity attenuates acute phosphate excretion after an oral challenge in females: A sex-specific effect of obesity on phosphate handling
Jaya K. Sharma BHSc, Mandy E. Turner PhD, Amanda S. Paynter BSc, Christine A. White MD, Emilie C. Ward, Michael A. Adams PhD, Rachel M. Holden MD
doi : 10.1111/dom.15362
Semaglutide, suicidal ideation and behaviour: A resting state functional magnetic resonance imaging perspective
Barbara Verovnik MSc, Andrej Vovk PhD
doi : 10.1111/dom.15363
Improvements in post-challenge lipid response following tirzepatide treatment in patients with type 2 diabetes
Kieren J. Mather MD, Tamer Coskun MD, Edward J. Pratt MD, Zvonko Milicevic MD, Govinda Weerakkody PhD, Melissa K. Thomas MD, Axel Haupt MD, Giacomo Ruotolo MD
doi : 10.1111/dom.15365
Correction to Clinical features of generalized lipodystrophy in Turkey: A cohort analysis
doi : 10.1111/dom.15384
